FDA Clearance Tracker · P810002
BILEAFLET-CENTER OPENING CARDIAC VALVE
Last checked: Nov 20, 2026Latest source record: Dec 17, 1982 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 1982
Approved
Time to decision
694 days
Received Jan 22, 1981. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P810002
- Device name
- BILEAFLET-CENTER OPENING CARDIAC VALVE
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Jan 22, 1981
- Decided
- Dec 17, 1982
- Decision
- Approved
- Supplements
- 119 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- HEART-VALVE, MECHANICAL (LWQ)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LWQ. The earliest in FDA's data is P790018, decided Dec 23, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.